Conduct pre-NDA meeting with the FDA
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- Q1 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Expect pre-NDA meeting with FDA early 2021”
What we found
Evidence strength A What the grades mean
The company confirmed in an April 2021 filing that it held the pre-NDA meeting with the FDA in early 2021.
-
A Dare Bioscience, Inc. 8-K filed 2021-04-08
“Based on pre-NDA meeting with FDA early 2021, targeting NDA submission by end of 2Q2021.” ✓ confirmed on the page
Market reaction: the shares moved -13.0% against the S&P 500 over the three sessions around the disclosure (7 Apr 2021 to 12 Apr 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Conduct
- Deliverable
- pre-NDA meeting
- Where
- United States
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Dare Bioscience, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-DARE-021719 · Corrections policy